FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2003164422> ?p ?o ?g. }

• W2003164422 endingPage "1676" @default.
• W2003164422 startingPage "1665" @default.
• W2003164422 abstract "To apply and analyze the mechanisms of action of dimethyldioctadecylammonium bromide (DDA), a powerful adjuvant that does not have the side effects of the conventionally used Freund's adjuvants, in proteoglycan-induced arthritis (PGIA) and collagen-induced arthritis (CIA).PGIA and CIA were generated using standard immunization protocols with cartilage proteoglycan aggrecan (PG) or human type II collagen (CII) emulsified with Freund's complete adjuvant (CFA), and compared with PGIA and CIA generated using immunization protocols in which the same antigens were used in combination with the adjuvant DDA. Immune responses to immunizing and self PGs and CII, and the incidence, severity, and onset of arthritis were monitored throughout the experiments. In addition, a new, inexpensive, and powerful method of inducing arthritis using crude cartilage extracts is described.A significantly reduced onset period and a more severe arthritis were achieved in BALB/c mice immunized with cartilage PGs in DDA. PGs from bovine, ovine, and porcine cartilage, which otherwise have no effect or have only a subarthritogenic effect, and crude extracts of human osteoarthritic cartilage induced a 100% incidence with a very high arthritis score in BALB/c mice. The overall immune responses to either CII or PG were similar in antigen/CFA-immunized and antigen/DDA-immunized animals, but the Th1/Th2 balance shifted significantly toward a Th1 bias in DDA-injected animals with either PGIA or CIA.DDA, which was first used in autoimmune models, is a potent nonirritant adjuvant, which eliminates all undesired side effects of the Freund's adjuvants. DDA exerts a strong stimulatory effect via the activation of nonspecific (innate) immunity and forces the immune regulation toward Th1 dominance. These lines of evidence also suggest the possibility that seemingly innocuous compounds may exert an adjuvant effect in humans and may create the pathophysiologic basis of autoimmunity in susceptible individuals via the activation/stimulation of innate immunity." @default.
• W2003164422 created "2016-06-24" @default.
• W2003164422 creator A5012926852 @default.
• W2003164422 creator A5021374114 @default.
• W2003164422 creator A5026356960 @default.
• W2003164422 creator A5070349100 @default.
• W2003164422 creator A5080635223 @default.
• W2003164422 creator A5087306198 @default.
• W2003164422 date "2004-05-01" @default.
• W2003164422 modified "2023-10-10" @default.
• W2003164422 title "Achievement of a synergistic adjuvant effect on arthritis induction by activation of innate immunity and forcing the immune response toward the Th1 phenotype" @default.
• W2003164422 cites W1495122617 @default.
• W2003164422 cites W1818320070 @default.
• W2003164422 cites W1856044063 @default.
• W2003164422 cites W1965555677 @default.
• W2003164422 cites W1969250152 @default.
• W2003164422 cites W1976912963 @default.
• W2003164422 cites W1980990177 @default.
• W2003164422 cites W1981047016 @default.
• W2003164422 cites W1982425773 @default.
• W2003164422 cites W1983521458 @default.
• W2003164422 cites W1987224476 @default.
• W2003164422 cites W1987961062 @default.
• W2003164422 cites W1989069694 @default.
• W2003164422 cites W2017205852 @default.
• W2003164422 cites W2019675509 @default.
• W2003164422 cites W2023867475 @default.
• W2003164422 cites W2045338903 @default.
• W2003164422 cites W2045938630 @default.
• W2003164422 cites W2058983758 @default.
• W2003164422 cites W2060399949 @default.
• W2003164422 cites W2061622709 @default.
• W2003164422 cites W2066778824 @default.
• W2003164422 cites W2088616022 @default.
• W2003164422 cites W2093940374 @default.
• W2003164422 cites W2094663958 @default.
• W2003164422 cites W2096973745 @default.
• W2003164422 cites W2106781193 @default.
• W2003164422 cites W2137156643 @default.
• W2003164422 cites W2147041011 @default.
• W2003164422 cites W2152130111 @default.
• W2003164422 cites W2161929802 @default.
• W2003164422 cites W2170060039 @default.
• W2003164422 cites W2183579169 @default.
• W2003164422 cites W2331507609 @default.
• W2003164422 doi "https://doi.org/10.1002/art.20180" @default.
• W2003164422 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/15146438" @default.
• W2003164422 hasPublicationYear "2004" @default.
• W2003164422 type Work @default.
• W2003164422 sameAs 2003164422 @default.
• W2003164422 citedByCount "81" @default.
• W2003164422 countsByYear W20031644222012 @default.
• W2003164422 countsByYear W20031644222013 @default.
• W2003164422 countsByYear W20031644222014 @default.
• W2003164422 countsByYear W20031644222015 @default.
• W2003164422 countsByYear W20031644222016 @default.
• W2003164422 countsByYear W20031644222017 @default.
• W2003164422 countsByYear W20031644222018 @default.
• W2003164422 countsByYear W20031644222019 @default.
• W2003164422 countsByYear W20031644222020 @default.
• W2003164422 countsByYear W20031644222021 @default.
• W2003164422 countsByYear W20031644222022 @default.
• W2003164422 crossrefType "journal-article" @default.
• W2003164422 hasAuthorship W2003164422A5012926852 @default.
• W2003164422 hasAuthorship W2003164422A5021374114 @default.
• W2003164422 hasAuthorship W2003164422A5026356960 @default.
• W2003164422 hasAuthorship W2003164422A5070349100 @default.
• W2003164422 hasAuthorship W2003164422A5080635223 @default.
• W2003164422 hasAuthorship W2003164422A5087306198 @default.
• W2003164422 hasConcept C105702510 @default.
• W2003164422 hasConcept C136449434 @default.
• W2003164422 hasConcept C147483822 @default.
• W2003164422 hasConcept C203014093 @default.
• W2003164422 hasConcept C2777077863 @default.
• W2003164422 hasConcept C2777863537 @default.
• W2003164422 hasConcept C2779351315 @default.
• W2003164422 hasConcept C2780550940 @default.
• W2003164422 hasConcept C2780801004 @default.
• W2003164422 hasConcept C2781013607 @default.
• W2003164422 hasConcept C71924100 @default.
• W2003164422 hasConcept C8891405 @default.
• W2003164422 hasConceptScore W2003164422C105702510 @default.
• W2003164422 hasConceptScore W2003164422C136449434 @default.
• W2003164422 hasConceptScore W2003164422C147483822 @default.
• W2003164422 hasConceptScore W2003164422C203014093 @default.
• W2003164422 hasConceptScore W2003164422C2777077863 @default.
• W2003164422 hasConceptScore W2003164422C2777863537 @default.
• W2003164422 hasConceptScore W2003164422C2779351315 @default.
• W2003164422 hasConceptScore W2003164422C2780550940 @default.
• W2003164422 hasConceptScore W2003164422C2780801004 @default.
• W2003164422 hasConceptScore W2003164422C2781013607 @default.
• W2003164422 hasConceptScore W2003164422C71924100 @default.
• W2003164422 hasConceptScore W2003164422C8891405 @default.
• W2003164422 hasIssue "5" @default.
• W2003164422 hasLocation W20031644221 @default.
• W2003164422 hasLocation W20031644222 @default.
• W2003164422 hasOpenAccess W2003164422 @default.
• W2003164422 hasPrimaryLocation W20031644221 @default.

• next